CNBC Television
@CNBCtelevision·3.4M subscribers·157.5K videos
Lilly’s Van Naarden: Nothing is off the table for dealmaking
Posted
June 3, 2026
Views
749
Likes
6
Engagement
0.80%
June 3, 2026
749
6
0.80%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
9:19Now PlayingCNBC’s Angelica Peebles sits down with Lilly’s President of Oncology and Head of Business Development at the largest global cancer conference, ASCO. Van Naarden says that when it comes to choosing the right companies to go after, he’s driven by the most compelling science. Lilly is navigating how to spend it’s GLP-1 windfall and most recently inked four deals that expanded the portfolio into the infectious disease space.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
